LUNG ALERT: Budesonide-formoterol reliever therapy in asthma

Quint, J. K.
November 2006
Thorax;Nov2006, Vol. 61 Issue 11, p985
Academic Journal
The article discusses the study on the use of budesonide-formoterol reliever therapy as an asthma treatment. The subjects were 3394 patients with moderate and severe asthma, which were randomly given budesonide-formoterol maintenance therapy plus one of budesonide-formoterol, formoterol and terbutaline. Findings showed that reduction of severe exacerbation by using budesonide-formoterol maintenance and reliever therapy was not determined.


Related Articles

  • It pays to pick beclometasone/formoterol for asthma in Spain.  // PharmacoEconomics & Outcomes News;11/15/2008, Issue 566, p9 

    The article discusses studies being done on the use of beclometasone/formoterol in treating patients with moderate-severe asthma in Spain, presented at the 18th Annual Congress of the European Respiratory Society. Researcher from Spain assessed the efficiency of beclometasone/formoterol against...

  • Review: formoterol increases serious adverse events in children and adults with chronic asthma. Peters, Jay // Evidence Based Medicine;Jun2009, Vol. 14 Issue 3, p12 

    The article presents a study which compares the effects of inhaled formoterol once or twice daily for 12 weeks with placebo or short-acting beta 2 agonists in treating children and adults with chronic asthma. Result shows that both can cause mortality and can cause non-fatal serious adverse...

  • Budesonide plus formoterol associated with better control of persistent asthma control than gold standard therapy.  // Formulary;Aug2007, Vol. 42 Issue 8, p490 

    The article focuses on the therapeutic use of budesonide/formoterol in controlling persistent asthma. Budesonide/formoterol was found as better maintenance and reliever therapy in providing asthma control. The use of these steroids offers a significant better treatment option which has been...

  • Formoterol Oral Inhalation.  // AHFS Consumer Medication Information;Oct2017, p1 

    Formoterol is used to treat wheezing, shortness of breath, and breathing difficulties caused by asthma and chronic obstructive pulmonary disease (COPD; a group of lung diseases that includes chronic bronchitis and emphysema). It also is used to prevent breathing difficulties (bronchospasm)...

  • SkyePharma: hope worth sharing?  // PharmaWatch: Monthly Review;Dec2005, Vol. 4 Issue 12, p29 

    The article reports that SkyePharma Inc. is developing Flutiform for the U.S. asthma market. Flutiform is a fixed-dose combination of formoterol, a long-acting bronchodilator and fluticasone, an inhaled corticosteroid. The initial indication for Flutiform will be asthma, with a chronic...

  • Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. Price, David B.; Williams, Angela E.; Yoxall, Sally // Respiratory Research;2007, Vol. 8, p46 

    Background: Improving patients' health-related quality of life (HRQoL) is recognized as a fundamental part of asthma management. The aims of this study were to evaluate the long-term efficacy (including symptom-free days and exacerbations) and impact on HRQoL of a stable-dose regimen of...

  • Combined budesonide and formoterol for maintenance and relief provided better asthma control than budesonide for maintenance and terbutaline for relief. Rabe, K. F.; Pizzichini, E.; Ställberg, B. // Evidence Based Medicine;Oct2006, Vol. 11 Issue 5, p138 

    The article presents a study on the effectiveness of the combination of budesonide and formoterol in treating patients with mild to moderate asthma. The result showed that budesonide and formoterol in a single inhaler was more effective than a higher dose of budesonide for maintenance plus...

  • Salbutamol.  // Reactions Weekly;9/29/2007, Issue 1171, p24 

    The article presents a case study of a 41-year-old man, who had a 40 pack/year smoking history and a 3-year history of asthma, experienced bronchoconstriction following inhalation of salbutamol for asthma exacerbation. After receiving methylprednisolone and formoterol, he felt breathless and...

  • Inhaled corticosteroid therapy for patients with persistent asthma: Learnings from studies of inhaled budesonide. Chipps, Bradley E. // Allergy & Asthma Proceedings;May/Jun2009, Vol. 30 Issue 3, p217 

    Inhaled corticosteroids (ICSs) are recommended for patients with asthma who use a short-acting β2-adrenergic agonist more than twice weekly—a key indicator of disease persistency. Much knowledge about the long-term benefits of ICSs in persistent asthma stems from studies of the ICS...


Read the Article


Sign out of this library

Other Topics